Precore mutant hepatitis B virus-associated fulminant hepatitis during infliximab therapy for rheumatoid arthritis

A 73-year-old female, who suffered from rheumatoid arthritis for 10 years, developed precore mutant hepatitis B virus-associated fulminant hepatitis after 1 year of infliximab therapy and subsequent methotrexate withdrawal. We emphasize the importance of preemptive antiviral therapy before starting...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuwabara, Hiroko, Fukuda, Akira, Tsuda, Yasuhiro, Shibayama, Yuro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594820/
https://www.ncbi.nlm.nih.gov/pubmed/20379839
http://dx.doi.org/10.1007/s10067-010-1438-y
_version_ 1782262350612529152
author Kuwabara, Hiroko
Fukuda, Akira
Tsuda, Yasuhiro
Shibayama, Yuro
author_facet Kuwabara, Hiroko
Fukuda, Akira
Tsuda, Yasuhiro
Shibayama, Yuro
author_sort Kuwabara, Hiroko
collection PubMed
description A 73-year-old female, who suffered from rheumatoid arthritis for 10 years, developed precore mutant hepatitis B virus-associated fulminant hepatitis after 1 year of infliximab therapy and subsequent methotrexate withdrawal. We emphasize the importance of preemptive antiviral therapy before starting infliximab administration and withdrawing immunosuppressive drugs.
format Online
Article
Text
id pubmed-3594820
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-35948202013-03-14 Precore mutant hepatitis B virus-associated fulminant hepatitis during infliximab therapy for rheumatoid arthritis Kuwabara, Hiroko Fukuda, Akira Tsuda, Yasuhiro Shibayama, Yuro Clin Rheumatol Case Report A 73-year-old female, who suffered from rheumatoid arthritis for 10 years, developed precore mutant hepatitis B virus-associated fulminant hepatitis after 1 year of infliximab therapy and subsequent methotrexate withdrawal. We emphasize the importance of preemptive antiviral therapy before starting infliximab administration and withdrawing immunosuppressive drugs. Springer-Verlag 2010-04-09 2013 /pmc/articles/PMC3594820/ /pubmed/20379839 http://dx.doi.org/10.1007/s10067-010-1438-y Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Case Report
Kuwabara, Hiroko
Fukuda, Akira
Tsuda, Yasuhiro
Shibayama, Yuro
Precore mutant hepatitis B virus-associated fulminant hepatitis during infliximab therapy for rheumatoid arthritis
title Precore mutant hepatitis B virus-associated fulminant hepatitis during infliximab therapy for rheumatoid arthritis
title_full Precore mutant hepatitis B virus-associated fulminant hepatitis during infliximab therapy for rheumatoid arthritis
title_fullStr Precore mutant hepatitis B virus-associated fulminant hepatitis during infliximab therapy for rheumatoid arthritis
title_full_unstemmed Precore mutant hepatitis B virus-associated fulminant hepatitis during infliximab therapy for rheumatoid arthritis
title_short Precore mutant hepatitis B virus-associated fulminant hepatitis during infliximab therapy for rheumatoid arthritis
title_sort precore mutant hepatitis b virus-associated fulminant hepatitis during infliximab therapy for rheumatoid arthritis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594820/
https://www.ncbi.nlm.nih.gov/pubmed/20379839
http://dx.doi.org/10.1007/s10067-010-1438-y
work_keys_str_mv AT kuwabarahiroko precoremutanthepatitisbvirusassociatedfulminanthepatitisduringinfliximabtherapyforrheumatoidarthritis
AT fukudaakira precoremutanthepatitisbvirusassociatedfulminanthepatitisduringinfliximabtherapyforrheumatoidarthritis
AT tsudayasuhiro precoremutanthepatitisbvirusassociatedfulminanthepatitisduringinfliximabtherapyforrheumatoidarthritis
AT shibayamayuro precoremutanthepatitisbvirusassociatedfulminanthepatitisduringinfliximabtherapyforrheumatoidarthritis

Ejemplares similares